Navigation Links
Cell Therapeutics, Inc. (CTI) to Present at Three Upcoming Investor Conferences
Date:10/12/2008

SEATTLE, Oct. 13 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) has been selected to present at three upcoming investor conferences. The conferences include the 7th Annual BIO Investor Forum in San Francisco in October, the 19th Annual Oppenheimer & Co. Healthcare Conference, and the 9th Annual Acumen BioFin Rodman & Renshaw Healthcare Conference in November, both in New York City.

The presentations will be webcast live with slides, and available for replay after the presentation at http://www.celltherapeutics.com.

BIO Investor Forum

CTI Presentation: Thursday, October 30, 2008

8:00 AM PT/11:00 AM ET/4:00 PM CET

Room TBA, Palace Hotel, San Francisco

Oppenheimer & Co. Healthcare Conference

CTI Presentation: Monday, November 3, 2008

8:00 AM ET/2:00 PM CET/5:00 AM PT

Astor Room, Waldorf-Astoria Hotel, New York City

Acumen BioFin Rodman & Renshaw Healthcare Conference

CTI Presentation: Tuesday, November 11, 2008

10:45 AM EST/4:45 PM CET/7:45 AM PST

Kennedy I, New York Palace Hotel, New York City

Media Contact: Investors Contact:

Cell Therapeutics, Inc. Cell Therapeutics, Inc.

Dan Eramian Ed Bell

T: 206.272.4343 T: 206.272.4345

F: 206.272.4434 Lindsey Jesch Logan

E: media@ctiseattle.com T: 206.272.4347

http://www.celltherapeutics.com/press_room F: 206.272.4434


SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes
2. Intarcia Therapeutics, Inc. Announces Appointment of Kenneth Luskey, M.D. as Vice President, Clinical Research
3. Cell Therapeutics, Inc. Announces Reverse Stock Split
4. Cell Therapeutics, Inc.s Second Quarter 2008 Financial Results
5. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
6. Zenobia Therapeutics, Inc. Receives Michael J. Fox Foundation for Parkinsons Research Award for Work on PD-implicated Protein LRRK2
7. Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants
8. Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company
9. Shareholders Approve All Matters Proposed by Cell Therapeutics, Inc. at Special Meeting in Lieu of Annual Meeting of Shareholders
10. Cell Therapeutics, Inc. Repays $11.0 million Balance of 2008 Convertible Debt
11. Cell Therapeutics, Inc. Special Meeting in Lieu of Annual Meeting of Shareholders Scheduled for Thursday, June 19, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2008)... Histogen, Inc., a regenerative medicine compa...ewborn fibroblasts, will be featured in an upcomin...st Century Breakthroughs for Biomedical Research s...EB) December 5, 2008 -- Histogen, Inc., a regenera...n the products of newborn fibroblasts, will be fea...
(Date:12/5/2008)... Dec. 5 Genomic Health,...ompany will present results from,four studies at ...m, taking,place December 10-14, 2008, at the Henr...ies analyze Oncotype DX(R), the company,s multi-ge...to predict the likelihood of chemotherapy,benefit...
(Date:12/5/2008)...Dec. 5 Senesco Technolog...next US: SNT) announced today that its Development...o.com ("Harris Moran") has been terminated by mut...nnounced corporate restructuring. , , Harr...agrain, restructured its vegetable seed operations...
(Date:12/5/2008)... fistula closures observed in PRECiSE 2 trial unde...(R) every four weeks , , HOLLYWOOD, Fla., D...s week by UCB at Advances in Inflammatory Bowel Di...s Clinical & Research Conference, demonstrated...e Crohn,s disease patients who had open fistulas a...
Breaking Biology Technology:Histogen Featured on Economic Report Television Series 2Genomic Health to Present Multiple New Studies at 31st Annual San Antonio Breast Cancer Symposium 2Genomic Health to Present Multiple New Studies at 31st Annual San Antonio Breast Cancer Symposium 3Senesco and Harris Moran Mutually Agree to Terminate Development and License Agreement Due to Restructuring 2Senesco and Harris Moran Mutually Agree to Terminate Development and License Agreement Due to Restructuring 3New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 2New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 3New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 4New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 5New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 6New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 7New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 8New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 9
...pose , Normal phase chromatography can b...the API 3000 LC/MS/MS System. , Overview ...ies have placed greater importance on examining th...ral center. Isomerspecific pharmaceuticals often e...nd reduced side effects when compared to racemic p...
...pose , Increased throughput in drug deve... 3000 LC/MS/MS System for N-in-1 experiments. Pate...ole in maximizing throughput by enabling faster sc... Overview , A significant area in whic...-1 studies (also referred to as cassette dosing or...
...al Analysis of Gene Expression (SAGE) is a sequenc...tially expressed genes by comparative analyses. SA...ve methods available for detailed analysis of larg...ofile of the expressed genes. 1 SAGE provides an ...els of genes expressed in a specimen. The ability ...
...pose , A previously published applicatio... for the simultaneous determination of four immuno... (TAC, aka FK-506), Sirolimus (SIR, aka Rapamycin)...hod is based on a simple and robust hardware confi...compromising precision and accuracy. Since this me...
Other Biology Technology:Separation and Quantitation of R and S Enantiomers using Normal Phase Chromatography on an API 3000 LC/MS/MS System 2Separation and Quantitation of R and S Enantiomers using Normal Phase Chromatography on an API 3000 LC/MS/MS System 3Detection of N-in-1 Experiments: Extending the Range of N Using the API 3000 LC/MS/MS System 2Detection of N-in-1 Experiments: Extending the Range of N Using the API 3000 LC/MS/MS System 3Serial Analysis of Gene Expression Using ABI PRISM DNA Sequencers and BigDye Terminators 2Serial Analysis of Gene Expression Using ABI PRISM DNA Sequencers and BigDye Terminators 3Serial Analysis of Gene Expression Using ABI PRISM DNA Sequencers and BigDye Terminators 4Serial Analysis of Gene Expression Using ABI PRISM DNA Sequencers and BigDye Terminators 5A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA) 2A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA) 3A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA) 4A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA) 5
(Date:12/4/2008)...am led by Craig Pikaard, Ph.D., WUSTL professor of...gh in understanding the phenomenon of nucleolar do...f ribosomal RNA genes in a hybrid plant or animal....ominance is some of the same machinery that can go...is collaborators, research may have important impl...
(Date:12/4/2008)...ksburg, Va. -- The Virginia Tech Wake Forest Univ...nce,s Center for Injury Biomechanics has received ..., The Office of the Deputy Chief of Staff of the... for research that could ultimately help save eyes... with facial injury. , The center was selected ...
(Date:12/4/2008)...ew Rochelle, NY, December 4, 2008Researchers are t...se (PI3-kinase) pathway as studies continue to dem...presses tumor growth, reports Genetic Engineering...olved in angiogenesis, cell growth, differentiatio...3/AKT/mTOR pathway, which plays a key role in canc...
(Date:12/4/2008)...RGINIA KEY, Fla. -- If you,re looking for bonefish...e about 321,000 to choose from, and that is down s...y due to increased participation among those who a... of Miami,s Rosenstiel School of Marine and Atmosp...onefish census, in conjunction with the conservati...
Breaking Biology News(10 mins):Researchers solve piece of large-scale gene silencing mystery 2Researchers solve piece of large-scale gene silencing mystery 3Researchers solve piece of large-scale gene silencing mystery 4New dummy design and development wins US Department of Defense award 2Bonefish census reveals population holding steady 2AZoOptics com The A to Z of Optics Launched By AZoNetwork 4554 1AZoOptics com The A to Z of Optics Launched By AZoNetwork 4554 2Genasense 28R 29 Data in Patients with Advanced Melanoma to be Featured at 4th International Melanoma Congress 649 1Genasense 28R 29 Data in Patients with Advanced Melanoma to be Featured at 4th International Melanoma Congress 649 2Genasense 28R 29 Data in Patients with Advanced Melanoma to be Featured at 4th International Melanoma Congress 649 3Artists for a New South Africa Will be Shaking The Blues at Gala Benefit November 15 With Performances by Erykah Badu Nikka Costa Keb Mo Taj Mahal 647 1Artists for a New South Africa Will be Shaking The Blues at Gala Benefit November 15 With Performances by Erykah Badu Nikka Costa Keb Mo Taj Mahal 647 2Artists for a New South Africa Will be Shaking The Blues at Gala Benefit November 15 With Performances by Erykah Badu Nikka Costa Keb Mo Taj Mahal 647 3Specialists in infectious disease and global health convene at Philadelphia meeting 1483 1Specialists in infectious disease and global health convene at Philadelphia meeting 1483 2
...esearchers at the University at Buffalo has been s...with human breast-cancer tumors and to inhibit the...re than 50 percent. , The antibody, named JAA-F11,...wn as TF-Ag, which aids the adhesion and spread of... kill the cancer cells, it blocked stages of cance...
...versity of Minnesota, Extension food scientist Joe...th a water-based electrochemical activation system...i. , While electrolyzed water systems are not new...ntists, is unique because it produces a pH-neutral...avors when sprayed on food. The system is environm...
... biochemical marker linked to sleep loss, an enzym...ctivity when sleep deprivation is prolonged. , Res... of biomarkers that will aid diagnosis and treatme...the risk of falling asleep at the wheel of a car o... for the holiday season and long drives to distant...
...an be accelerated with the assistance of the molec... a team of researchers at the U.S. Department of E...und. Nanoparticles, particles with dimensions on t...ly be used for more efficient energy generation an...agnosing and treating disease. Learning how to con...
Other Biology News:Antibody extends life of mice with breast cancer 2First biomarker for human sleepiness identified in fruit flies 2First biomarker for human sleepiness identified in fruit flies 3Nanoparticle assembly enters the fast lane 2
MAb to Verotoxin II (SLT-2a) Verotoxin II (Shiga-like) A subunit (SLT-2a)
TSQ Quantum Discovery MAX from Thermo Scientific
BD Falcon microtest assay plate. 1536 well 12l, black, flat-bottom PS. Polystyrene, nonsterile, no lid. (15/sp, 60/ca) Packaging: 15 / pack, 60 / case
...cence, minimal light scatter and reduced crosstalk...e surface is hydrophobic in nature and binds biomo...itable primarily for the immobilization of large m...ophobic regions that can interact with the surface...
Biology Products: